Date published: 2025-12-24

1-800-457-3801

SCBT Portrait Logo
Seach Input

MRP7 Inhibitors

MRP7 inhibitors encompass a diverse collection of organic compounds characterized by their distinctive molecular structures and their ability to selectively interact with specific components of the Multidrug Resistance-Associated Protein 7 (MRP7). MRP7, a member of the ATP-binding cassette (ABC) transporter family, plays a vital role in cellular drug transport and detoxification processes. The development of MRP7 inhibitors is driven by a comprehensive understanding of the intricate biochemical pathways involving MRP7, which contribute to the modulation of cellular responses to various compounds. MRP7 inhibitors are meticulously designed through a combination of rational drug design approaches and empirical experimentation. Researchers utilize advanced techniques to engineer the structural attributes of these inhibitors, enabling them to selectively bind to distinct regions of MRP7 or its associated partners. This selective binding capacity empowers MRP7 inhibitors to modulate the activity of MRP7, thereby influencing the complex molecular processes that govern cellular drug transport and resistance. The chemical structures of MRP7 inhibitors display notable diversity, reflecting the intricate nature of MRP7 and its multifaceted interactions within cellular pathways. The design of these inhibitors benefits from insights of structural biology, computational modeling, and meticulous biochemical analyses. By meticulously investigating the molecular interactions involving MRP7, researchers can strategically design inhibitors with tailored attributes that selectively interfere with MRP7-associated functions. MRP7 inhibitors hold significant promise as valuable tools for advancing scientific understanding of cellular drug transport and detoxification mechanisms. By perturbing MRP7-mediated pathways, these inhibitors provide a means to unravel the intricate web of molecular events underlying cellular responses to various compounds. The development of MRP7 inhibitors exemplifies the ongoing commitment to unraveling the nuanced roles of MRP7 in cellular physiology.
Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Ko 143

461054-93-3sc-204030
sc-204030A
1 mg
10 mg
$107.00
$256.00
21
(1)

Ko143 is a well-known small molecule inhibitor that targets MRPIt has been extensively studied for its potential effects on modulating MRP7-mediated drug transport and resistance.

Reversan

313397-13-6sc-296262
sc-296262A
10 mg
50 mg
$185.00
$781.00
3
(0)

Reversan is a synthetic compound that has been explored for its potential to inhibit MRPIt may modulate MRP7-mediated drug resistance and transport.

SN 38

86639-52-3sc-203697
sc-203697A
sc-203697B
10 mg
50 mg
500 mg
$117.00
$335.00
$883.00
19
(3)

SN-38 is the active metabolite of irinotecan and has been reported to inhibit MRPIt may influence cellular drug transport and resistance processes.

2-(4-Methoxyphenyl)-α-2-piperidinyl-4-quinolinemethanol Dihydrochloride

858474-14-3sc-483347
10 mg
$400.00
(0)

NSC23925 is a small molecule inhibitor that has been studied for its potential effects on MRPIt may impact MRP7-mediated drug transport and resistance.

Dipyridamole

58-32-2sc-200717
sc-200717A
1 g
5 g
$30.00
$100.00
1
(1)

Dipyridamole is a known antiplatelet agent that has been investigated for its inhibitory effects on MRPIt may modulate MRP7-mediated drug transport processes.

Lucanthone Hydrochloride

548-57-2sc-396381
sc-396381A
10 mg
5 mg
$360.00
$220.00
(0)

Lucanthone is a compound that has been investigated for its potential effects on inhibiting MRPIt may impact MRP7-mediated drug transport processes.

GW 3965 hydrochloride

405911-17-3sc-224011
sc-224011A
sc-224011B
5 mg
25 mg
1 g
$137.00
$474.00
$3060.00
(1)

GW3965 is a compound that has been explored for its potential to inhibit MRPIt may modulate MRP7-mediated drug transport and resistance.